| Ticker Details |
Retractable Technologies, Inc
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes.
|
| IPO Date: |
May 4, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$21.85M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 3.73%
|
| Avg Daily Range (30 D): |
$0.01 | 1.88%
|
| Avg Daily Range (90 D): |
$0.02 | 3.03%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.11M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
.03M |
| Trade Size |
| Avg Trade Size (Sh.): |
220 |
| Avg Trade Size (Sh.) (30 D): |
352 |
| Avg Trade Size (Sh.) (90 D): |
127 |
| Institutional Trades |
| Total Institutional Trades: |
35 |
| Avg Institutional Trade: |
$1.35M |
| Avg Institutional Trade (30 D): |
$3.19M |
| Avg Institutional Trade (90 D): |
$3.19M |
| Avg Institutional Trade Volume: |
.17M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.14M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
317K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.12
|
$.09
|
$-.14
|
|
Diluted EPS
|
$-.12
|
$.09
|
$-.14
|
|
Revenue
|
$33.9M
|
$7.2M
|
$7.18M
|
|
Gross Profit
|
$-.49M
|
$.19M
|
$-.84M
|
|
Net Income / Loss
|
$-3.37M
|
$2.83M
|
$-4.23M
|
|
Operating Income / Loss
|
$-22.68M
|
$-5.15M
|
$-6.17M
|
|
Cost of Revenue
|
$34.39M
|
$7.01M
|
$8.02M
|
|
Net Cash Flow
|
$-.4M
|
$-.12M
|
$.18M
|
|
PE Ratio
|
|
|
|
|
|
|